Immunogenicity and Bioassay Summit - 2018 - CD

Wrapping up its ninth year, CHI’s Immunogenicity and Bioassay Summit was host to industry, academia and regulatory authorities who shared new ways of overcoming immunogenicity and bioassay challenges at 3 co-located conferences, 4 short courses, 2 training seminars and the Bioassays for Immuno-Oncology symposium. Cambridge Healthtech Institute (CHI) would like to thank all the speakers, attendees, sponsors, and exhibitors for their participation. The 2017 summit featured:

• 300 Delegates from 165 Companies
• 75 Scientific Presentations & Case Studies, including FDA
• 25 Poster Presentations
• 20 Countries Represented
• 16 Exhibitors